6-KThe Wire
Telix Pharmaceuticals Ltd files 6-K
Filed Apr 14, 2026 · 2mo ago · Accession 0001140361-26-014540
Plain English
Telix Pharmaceuticals Limited successfully priced and upsized its convertible bonds to US$600 million. This report is a Form 6-K filed on April 14, 2026, containing an announcement about this financing event. (2) * Reporting currency: Not applicable as no financial statements are included.
Filing details
- Company
- Telix Pharmaceuticals Ltd
- Ticker
- TLX
- CIK
- 2007191
- Form type
- 6-K
- Filing date
- Apr 14, 2026
- Report date
- Apr 14, 2026
- Document
- ef20070388_6k.htm
- Size
- 419 KB
More from TLX
6-KThe WireJul 2, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSMay 21, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSApr 23, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSApr 21, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSApr 20, 20266-KThe WireApr 14, 2026